Five Neurodevice Startups Target the Brain. Brain Waves: The field of neurotechnology, the focus of this blog, encompasses advances in brain science (neurons), information technology (bits) and bioengineering (genes). Up for discussion and analysis: the political, economic, ethical, and social forces that will shape the future of what will be one of the most important and fascinating stories of the coming decades.

About this author

Zack Lynch is author of The Neuro Revolution: How Brain Science Is Changing Our World (St. Martin's Press, July 2009).
He is the founder and executive director of the Neurotechnology Industry Organization (NIO) and co-founder of NeuroInsights. He serves on the advisory boards of the McGovern Institute for Brain Research at MIT, the Center for Neuroeconomic Studies, Science Progress, and SocialText, a social software company. Please send newsworthy items or feedback - to Zack Lynch.
Follow me on Twitter at @neurorev

Receive by email

GUEST AUTHOR ARCHIVES

In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

« Getting Government Grants in Neurotechnology | Main | Cutting Edge Neurodevice Technologies - MCS and TMS »

October 23, 2005

Five Neurodevice Startups Target the Brain

Posted by Zack Lynch

Notes from Startups:

Medtrode, Souhile Assaf, CEO: Patented multi-function Deep Brain Stimulation electrode, 75% smaller than what is on the market enabling new treatment paradigms. Electrodes stimulate and record simultaneously. US Patent issued 10 days ago.

Andara Life Science Inc. Mark Carney, CEO: Bioengineering platform; an oscillating field stimulator, implanted in muscle of acute and sub acute injury.

GentCorp, Elisabeth Hager, CEO: Newest venture of Mr. Wilson Greatbatch (inventor of pacemaker). Inventing power source solutions for the neurostimulation market because neurodevices are limited by power. Developed a rechargeable battery for neurostimulation which allows for higher charge and greater longevity than cardiodevices. Battery can last between 10-40 years.

Neuronetrix K.C. Fadem, COO: Neuronetrix has developed an easy-to-use ERP-based system for widespread, high-throughput screening of a variety of neurological disorders. The company’s, patent pending COGNISION™ System uses advanced micro-electronics integrated into a patient-friendly headset to automatically perform a variety of ERP tests. This is the only company I've seen in person who is targeting EEG neuroinformatics market.

NeuroNexus Technologies Daryl Kipke, CEO: The company is focused on becoming the leading supplier of implantable microscale probe systems for establishing chemical and electrical interfaces to the nervous system. Currently a boot strapped startup looking for investment.

Comments (0) + TrackBacks (0) | Category: Neurodevices

POST A COMMENT

Thanks for signing in, . Now you can comment. (sign out)

(If you haven't left a comment here before, you may need to be approved by the site owner before your comment will appear. Until then, it won't appear on the entry. Thanks for waiting.)